Companies in the life sciences and health care industry navigated unparalleled challenges in 2020. The pandemic forced the development and adoption of new technologies and innovations resulting in massive investments into virtual
health solutions, telehealth products, and related cybersecurity measures. It also spurred new debate over drug and medical device regulatory standards, as many regulators permitted emergency use authorizations and granted temporary waivers for compliance obligations. In the transactional space, companies found new ways to collaborate virtually, as the need for cooperation grew.
 
In the 2021 edition of our Life Sciences and Health Care Horizons publication, our global team identifies a number of evolving trends that are shaping the future of the industry. With perspectives from around the world in Asia-Pacific, Europe, Latin America and the U.S., we help you tackle specific legal challenges and report on the extraordinary progress and opportunities for the future of human health.

Download Attachment

See all Member News